From 2013 to 2015, feline patients who received a diagnosis of diabetes were given a variety of tests, Glucogenic products and prescription diets. Our vet informatics statistics demonstrate that about 180,000 cats with diabetes mellitus (DM) received only a prescription diet. Obesity is the most important acquired risk factor for diabetes, as overweight cats have a diabetes risk almost 5 times higher than normal weight cats. The highest remission rates in diabetic cats (>80%) were reported for those felines treated with a very low-carbohydrate diet. However, ~ approximately 25%–30% of diabetic cats in remission will relapse and require insulin treatment. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053045/)
Vet Informatics proprietary information indicates that the number of DM cats who received diet food for treatment, alone or in combination with Glucogenic regulators, was about 240,000. There were about 20,800 DM cats that received an average of 63,000 Glucogenic Replacement Therapy (GRT) products without a prescription diet. At least 75% of diabetic cats are insulin dependent, but up to 25% of cats can be controlled, at least temporarily, with oral hypoglycemic drugs. Diabetic remission occurs in approximately 30% of patients, usually within 1-4 months of good glycemic control being established. (https://www.sciencedirect.com/science/article/pii/S0195561601500042)
Vetinformatics Research used a rigorously qualified 750+ primary care small animal practice sample of over 1 million cats per year to research canine and feline prevalence rates for all presenting veterinary maladies, disorders, disease, surgeries and other services performed to provide these veterinary prevalence statistics. All prevalence counts, demographic statistics, and market sizes were also triangulated to another veterinary database of marketed products that tie to these disorders as a source for validation to ensure projections were reliable within +/- 5% level of accuracy. Triangulation to the national veterinary medical case history study of over 500,000 medical records over the last 10 years sized the Glucogenic Regulator Market at around $32 million in Product Sales at the Veterinary Clinic purchasing level at that time. Vetinformatics projection factor was derived from a consistent 3 year visiting felines in a stratified group of around 600 subset of the 750+ sample of small animal practice clinics with invoices for 36 months (2013-2015), containing about 1,300 veterinarians (from a universe of around 55-56,000 small animal general practice veterinarians) and these clinics were distributed over 5 geographical regions in the continental US and appropriately weighted.
“The Glucogenic Regulator Market (GRM) was sized at $32 million“
Feline diabetic patients received a variety of tests, Glucogenic products and prescription diets. There were about 180,000 unique cats receiving only prescription food. These patients revisited the clinic during the year to obtain an average of 708,273 invoiced diet food items, or approximately 4 items per cat per year. The average number of unique cats receiving diet food for treatment, alone or in combination with Glucogenic regulators, is about 240,000 and they come to the clinic about 5 times a year to get those items.
Patients receiving each type of treatment:
© All right reserved.